Advice
Following an abbreviated submission.
Travoprost/timolol (Duotrav) eye drops are accepted for use in NHS Scotland for whom this is an appropriate combination of agents. They decrease intra-ocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues alone.
There is no significant additional cost associated with the combination product compared with the individual components and it allows patients to administer fewer drops.
Download detailed advice28KB (PDF)
Medicine details
- Medicine name:
- Travoprost/timolol (Duotrav®)
- SMC ID:
- 294/06
- Indication:
- Decrease of intraocular pressure (IOP) in open-angle glaucoma or ocular hypertension
- Pharmaceutical company
- Alcon Laboratories UK Ltd
- BNF chapter
- Eye
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 07 August 2006